UnitedHealth Revenue Grows by $14 billion in 2024
2024年7月16日 · For the second quarter of 2024, UnitedHealth’s earnings reached $98.9 billion, up almost $6 billion from the same quarter last year. The increase, company executives said, reflect growth at Optum and UnitedHealthcare. Second quarter adjusted earnings from operations were $8.7 billion and include business disruption from the Change Healthcare cyberattack.
Understanding “Delinking” in the PBM Legislation | AMCP 2024
2024年4月16日 · Many of the new rules Congress is considering in the still-fluid pharmacy benefit management (PBM) legislation would add reporting requirements to meet transparency goals but wouldn’t fundamentally disrupt the industry’s business practices.
AffirmedRx’s Efforts to Address PBM Transparency and Drive …
2024年11月25日 · “It’s going to be really hard to legislate our way out of it without having that law of unintended consequences,” he said. AffirmedRx has been engaging policymakers, with Baker and his team making over 60 trips in the last two years to Washington, D.C., to educate federal agencies about PBM practices.
What’s Changed In Hospice in 2024? - Managed Healthcare …
2024年8月5日 · Physician eligibility. Another change in the 2024 fiscal year is that CMS now requires that doctors who certify patients to be eligible for hospice care to be enrolled as a Medicare provider or be opted out in a valid manner.
Use of Copay Offset Programs Expected to Rise | AMCP Nexus 2024
2024年10月15日 · Just a small percentage of employers use alternative funding programs, including accumulators and maximizers. But approximately 60% of employers who do use these programs said in a survey they are effective at managing healthcare costs.
What the Trump Presidency Will Mean for U.S. Healthcare and …
2024年11月22日 · This webinar on "What the Trump Presidency Will Mean for U.S. Healthcare and Managed Care" includes panelists Lindsay Greenleaf, J.D., MBA; Ryann Hill, M.P.H. and Patrick Cooney, discussing possible changes to healthcare policies and programs under the Trump administration, including the future of the Inflation Reduction and Affordable Care Acts, PBM reform and Medicare Advantage.
Improving Your 2026 MA Star Ratings: Insights and …
2024年11月7日 · The release of the 2025 Medicare Advantage (MA) Star Ratings in October saw results trending downward for the third year in a row. Approximately 32% of plans saw a decrease in their rating, while 29% saw an increase.
Are Value-Based Contracts the Answer to Ultra-High-Priced Gene ...
2024年4月17日 · Last month, the FDA approved a gene therapy that will have the highest ever price for a new treatment: $4.25 million. Lenmeldy (atidarsagene autotemcel) is a one-time treatment and the first approved gene therapy to treat children with juvenile metachromatic leukodystrophy, a life-threatening inherited disease of the body’s metabolic system.
Two New FDA Approvals in Lung Cancer
On Dec. 4, 2024, the FDA granted accelerated approval for Bizengri (zenocutuzumab) for the treatment of advanced, unresectable or metastatic non-small cell lung cancer (NSCLC) or pancreatic cancer harboring neuregulin 1 (NRG1) gene fusions, also called NRG1 rearrangements, in adults who have had ...
A Hot Take: What the Trump Win Will Mean for U.S. Healthcare
2024年11月6日 · Johnson, a Louisiana Republican, referenced the GOP Doctors Caucus as a source of healthcare ideas. In the current Congress, the caucus consists of 16 Republicans physicians, pharmacists and dentists and is chaired by Rep. Andrew Harris, Maryland’s only Republican congressman and an obstetric anesthesiologist.